
Ask a doctor about a prescription for Accordeon
Oxycodone hydrochloride
Keep this leaflet, you may need to read it again.
In case of any doubts, consult a doctor or pharmacist.
This medicine has been prescribed to you by a doctor and should not be given to others.
The medicine may harm another person, even if their symptoms are the same.
The active substance of the medicine is oxycodone, which belongs to a group of strong painkillers.
Accordeon is used to treat severe pain that can only be adequately managed with opioid painkillers.
Accordeon is indicated for adults and adolescents over 12 years of age.
If the patient is allergic to oxycodone hydrochloride or any of the other ingredients of this medicine (listed in section 6).
If the patient has breathing difficulties, such as chronic obstructive pulmonary disease, severe asthma, or severe respiratory depression. The doctor will inform the patient if they have any of these conditions. Symptoms may include shortness of breath, coughing, and slower or weaker breathing.
If the patient has a disease in which the small intestine does not work properly (paralytic ileus), the stomach empties more slowly than it should (delayed gastric emptying), or severe abdominal pain.
If the patient has heart disease after long-term lung disease (cor pulmonale).
If the patient has moderate to severe liver impairment. If the patient has other long-term liver impairment, taking this medicine requires special recommendation by the doctor.
If the patient has constipation.
In children under 12 years of age.
Before starting to take Accordeon, the patient should discuss it with their doctor or pharmacist.
if the patient is elderly or weakened;
has hypothyroidism, as they may require a lower dose;
has liver or kidney disease;
has myxedema (a thyroid disorder in which the skin is dry, cold, and swollen);
has adrenal insufficiency (the adrenal glands do not work properly, which can cause symptoms such as weakness, weight loss, dizziness, nausea, or vomiting (e.g., Addison's disease);
has low blood pressure (hypotension);
has low blood volume (hypovolemia). This can occur in case of severe external or internal bleeding, severe burns, excessive sweating, severe diarrhea, or vomiting;
has toxic psychosis (a mental disorder caused by infection);
has disorders related to the gallbladder or bile ducts;
has intestinal inflammation;
has an enlarged prostate, which causes difficulty urinating in men;
has pancreatitis (which causes severe abdominal and back pain);
has severe headaches or nausea, as this may be a sign of increased intracranial pressure;
has breathing difficulties, such as severe lung disease. The doctor will inform the patient about this. Symptoms may include shortness of breath and coughing;
has a history of substance abuse or dependence;
has a history of seizures or convulsions;
has a history of head injury or increased intracranial pressure;
has a history of alcohol or drug abuse;
has a history of mental disorders or depression;
is taking other medicines that may interact with Accordeon.
If the patient notices any of the following symptoms while taking Accordeon, it may indicate that they are developing dependence or addiction.
If the patient has observed any of these symptoms, they should contact their doctor to discuss the best treatment plan, including the right time and safe way to stop the treatment (see section 3 "Stopping Accordeon treatment").
The patient should tell their doctor or pharmacist about all medicines they are currently taking or have recently taken, including those available without a prescription. If the patient takes Accordeon with other medicines, the effect of this medicine or other medicines may change.
The patient should tell their doctor or pharmacist if they are taking:
a type of medicine called a monoamine oxidase inhibitor or if they have taken this type of medicine in the last two weeks;
medicines that help them sleep or relax (e.g., sedatives or sleeping pills);
medicines used to treat depression (e.g., paroxetine);
medicines used to treat mental disorders (e.g., phenothiazine derivatives or neuroleptics);
other strong painkillers;
muscle relaxants;
medicines used to treat high blood pressure;
quinidine (a medicine used to treat rapid heartbeat);
cimetidine (a medicine used to treat stomach ulcers, indigestion, or heartburn);
antifungal medicines (e.g., ketoconazole, voriconazole, itraconazole, and posaconazole);
antibiotics (e.g., clarithromycin, erythromycin, or telithromycin);
medicines called "protease inhibitors" used to treat HIV (e.g., boceprevir, ritonavir, indinavir, nelfinavir, or saquinavir);
rifampicin (used to treat tuberculosis);
carbamazepine (a medicine used to treat epilepsy, seizures, or certain types of pain);
phenytoin (a medicine used to treat epilepsy or seizures);
the herbal remedy St. John's Wort (also known as Hypericum perforatum);
antihistamines;
medicines used to treat Parkinson's disease.
The patient should also inform their doctor about any recent anesthesia.
Consuming alcohol while taking Accordeon increases the feeling of drowsiness and may also increase the risk of serious side effects, such as slow breathing with the risk of respiratory arrest and loss of consciousness.
It is recommended that patients taking Accordeon do not drink alcohol.
The patient should avoid drinking grapefruit juice while taking this medicine.
Accordeon can be taken with or without food.
If the patient is pregnant or breastfeeding, thinks they may be pregnant, or plans to have a baby, they should consult their doctor or pharmacist before taking this medicine.
Pregnancy
there is limited experience with the use of oxycodone in pregnant women. Newborns of mothers who received oxycodone during the last 3-4 weeks before delivery may have severe breathing difficulties. Withdrawal symptoms can be observed in newborns of mothers receiving oxycodone treatment.
Breastfeeding
due to the risk of side effects, Accordeon should not be used during breastfeeding.
Oxycodone may impair alertness and reaction ability to such an extent that the patient may have reduced ability or be unable to drive vehicles and operate machines.
With balanced therapy, a complete ban on driving vehicles may not be necessary. The doctor should assess the patient's ability to drive vehicles individually.
The patient should consult their doctor to determine if and under what conditions they can drive a car.
To learn about possible side effects that may affect the ability to drive vehicles and concentrate, see section 4 "Side effects".
The medicine contains sucrose. If the patient has been diagnosed with intolerance to some sugars, they should consult their doctor before taking the medicine.
This medicine has been prescribed by a doctor to relieve severe pain for 12 hours.
This medicine should always be taken exactly as prescribed by the doctor.
In case of doubts, the patient should consult their doctor or pharmacist.
Before starting treatment and regularly during treatment, the doctor will discuss with the patient what to expect from Accordeon treatment, when and how long to take it, when to contact the doctor, and when to stop taking it (see also "Stopping Accordeon treatment").
Accordeon, 5 mg / 10 mg / 20 mg / 40 mg / 80 mg prolonged-release tablets
Adults and adolescents over 12 years of age
The usual initial dose is 10 mg of oxycodone hydrochloride every 12 hours.
The doctor will decide on the daily dose, the division of the daily dose into individual doses, and any possible change in dosage during treatment based on the patient's previous dosage.
Patients who have previously taken other strong opioid painkillers may be prescribed a higher initial dose by the doctor, taking into account their previous response to opioids.
Patients who have been taking Accordeon, 5 mg prolonged-release tablets according to a fixed schedule may need a fast-acting painkiller to quickly relieve breakthrough pain. Accordeon, 5 mg prolonged-release tablets are not intended for quick relief of breakthrough pain.
For the treatment of non-cancer pain, the daily dose of 40 mg of oxycodone hydrochloride is usually sufficient, but higher doses may be necessary. Patients with cancer pain usually require doses of 80 to 120 mg of oxycodone hydrochloride, which may be increased to 400 mg in special cases.
Treatment should be monitored, taking into account pain relief and other factors. Monitoring treatment allows for the selection of the best therapy, quick treatment of side effects, and decision-making regarding the continuation of treatment.
Elderly patients (over 65 years of age)
In the case of frail elderly patients who have not taken opioid medicines in the past, the initial dose is usually one 5 mg tablet taken every 12 hours. The doctor will prescribe the dose required for effective pain relief. The patient should inform their doctor if the taken doses do not provide pain relief.
Patients at risk
If the patient has kidney or liver disorders or has a low body mass, the doctor may recommend reducing the initial dose.
Accordeon, 5 mg, prolonged-release tablets
The tablets should be swallowed whole with a sufficient amount of liquid (½ glass of water) in the morning and evening, according to the established schedule (e.g., at 8 am and 8 pm), regardless of meals or with meals.
Accordeon, 10/20/40/80 mg, prolonged-release tablets
The tablets should be swallowed whole or broken into two parts with a sufficient amount of liquid (½ glass of water) in the morning and evening, according to the established schedule (e.g., at 8 am and 8 pm), regardless of meals or with meals.
The prolonged-release tablets should not be crushed or chewed, as this leads to the loss of their properties. Chewing and crushing Accordeon leads to the sudden release of the active substance into the body and the absorption of a potentially life-threatening dose of oxycodone (see "Taking a higher dose of Accordeon than recommended").
The medicine is packaged in child-resistant blister packs. The tablet cannot be pushed through the blister pack. The blister pack should be opened according to the following instructions:
In case of taking a higher dose of Accordeon than recommended, the patient should immediately consult their doctor, who will contact the local toxicology center if necessary.
Symptoms of overdose include: constricted pupils, breathing difficulties (respiratory depression), feeling of weakness, and low blood pressure. Overdose can lead to a life-threatening condition called toxic leukoencephalopathy. In severe cases, it can cause circulatory collapse, physical and mental numbness, loss of consciousness (coma), slow heart rate, and fluid accumulation in the lungs (pulmonary edema). Taking large doses of strong opioid painkillers can lead to death. The patient should absolutely avoid situations that require increased concentration, such as driving a car.
In case of taking a lower dose of Accordeon than recommended or missing a dose, pain relief may be difficult or impossible.
The patient can take the missed tablet if the next scheduled dose is to be taken in at least 8 hours. Then, the patient can continue taking the medicine as prescribed by the doctor.
The patient can also take the prolonged-release tablet if the next scheduled dose is to be taken in less than 8 hours; in this case, the next dose should be postponed by 8 hours.
As a rule, the medicine should not be taken more frequently than every 8 hours.
The patient should not take a double dose to make up for a missed dose.
The patient should not stop treatment without consulting their doctor.
If Accordeon treatment is no longer necessary, the doctor will gradually reduce the dose to avoid withdrawal symptoms.
In case of any further doubts about the use of this medicine, the patient should consult their doctor or pharmacist.
Like all medicines, Accordeon can cause side effects, although not everybody gets them.
All medicines can cause allergic reactions, although severe allergic reactions are rare.
The patient should immediately inform their doctorif they suddenly experience wheezing, difficulty breathing, swelling of the eyelids, face, or lips, rash, or itching, especially if these symptoms spread throughout the body.
The most serious side effect is a condition in which the patient breathes more slowly or weakly than they should (respiratory depression). In such a case, the patient should immediately inform their doctor.
As with all strong painkillers, there is a risk of dependence on this medicine.
Other possible side effects
Very common (may affect more than 1 in 10 people):
Common (may affect up to 1 in 10 people):
Uncommon (may affect up to 1 in 100 people):
Rare (may affect up to 1 in 1000 people):
Frequency not known (frequency cannot be estimated from the available data):
The patient may notice remnants of tablets in their stool. This should not affect the action of the medicine.
Measures
The doctor will take appropriate action if the patient experiences any of the above side effects. To prevent constipation, the patient should consume more fiber and drink more fluids. If the patient experiences nausea, the doctor should prescribe appropriate medicines.
If side effects occur, including any side effects not listed in the leaflet, the patient should inform their doctor or pharmacist. Side effects can be reported directly to the Department of Adverse Reaction Monitoring of Medicinal Products, Medical Devices, and Biocidal Products
Al. Jerozolimskie 181C
02-222 Warsaw
Phone: +48 22 49 21 301
Fax: +48 22 49 21 309
website: https://smz.ezdrowie.gov.pl
Side effects can also be reported to the marketing authorization holder.
Reporting side effects can help gather more information on the safety of the medicine.
The medicine should be stored out of sight and reach of children. This medicine should be stored in a closed and secure place to which other people do not have access. It can be very harmful and may cause death in a person it was not prescribed for.
The medicine should not be used after the expiration date stated on the blister pack or bottle after: "EXP". The expiration date refers to the last day of the specified month.
The term "Lot" on the packaging and blister pack means "Batch number".
The term "EXP" on the packaging and blister pack means "Expiration date".
The medicine should not be used if the patient notices that the tablets are damaged (broken or crushed).
There are no special precautions for storing the medicine.
Medicines should not be disposed of via wastewater or household waste. The patient should ask their pharmacist how to dispose of medicines they no longer use. This will help protect the environment.
The active substance of the medicine is oxycodone hydrochloride.
Each prolonged-release tablet contains 5 mg/10 mg/20 mg/40 mg/80 mg of oxycodone hydrochloride, which corresponds to 4.5 mg/9.0 mg/17.9 mg/36 mg/72 mg of oxycodone.
The other ingredients are:
Core:
sucrose, pellets (containing sucrose, cornstarch, hydrolyzates, colorants), hypromellose, talc, ethylcellulose, hydroxypropylcellulose, propylene glycol, sodium carmellose, microcrystalline cellulose, magnesium stearate, anhydrous colloidal silica
Coating:
5 mg and 20 mg: titanium dioxide (E 171), macrogol 3350, talc.
10 mg and 40 mg: titanium dioxide (E 171), macrogol 3350, talc, iron oxide red (E 172)
80 mg: macrogol 3350, talc, iron oxide red (E 172)
Accordeon, 5 mg, are white or almost white, convex, round prolonged-release tablets
Accordeon, 10 mg, are pink, oblong, convex prolonged-release tablets with a score line on both sides, along which the tablet can be divided into two equal parts.
Accordeon, 20 mg, are white or almost white, oblong, convex prolonged-release tablets with a score line on both sides, along which the tablet can be divided into two equal parts.
Accordeon, 40 mg, are pale pink, oblong, convex prolonged-release tablets with a score line on both sides, along which the tablet can be divided into two equal parts.
Accordeon, 80 mg, are red, oblong, convex prolonged-release tablets with a score line on both sides, along which the tablet can be divided into two equal parts.
Pack sizes:
10, 14, 20, 28, 30, 50, 56, 60, 98, 100, and 120 prolonged-release tablets packaged in PVC/PE/PVDC/Aluminum blister packs.
10, 20, 30, 50, 100 prolonged-release tablets packaged in HDPE bottles.
Not all pack sizes may be marketed.
Accord Healthcare Polska Sp. z o.o.
Taśmowa 7 Street
02-677 Warsaw
Phone: +48 22 577 28 00
Phast Gesellschaft für Pharmazeutische Qualitätsstandards mbH
Kardinal-Wendel-Strasse 16
66424 Homburg
Germany
Develco Pharma GmbH
Grienmatt 27,
79650 Schopfheim,
Germany
Accord Healthcare Polska Sp.z o.o.
Lutomierska 50 Street
95-200 Pabianice
Poland
| Netherlands | Oxycodon-HCl Accord Retard 5/10/20/40/80 mg tabletten met verlengde afgifte |
| Poland | Accordeon |
| Italy | Oxycodon Accord |
The best alternatives with the same active ingredient and therapeutic effect.
Discuss dosage, side effects, interactions, contraindications, and prescription renewal for Accordeon – subject to medical assessment and local rules.